All In Biotech

Drug Trial Radar · NCT02481830

Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung Cancer

An Open-label, Randomized, Phase 3 Study of Nivolumab or Chemotherapy in Subjects With Relapsed Small-cell Lung Cancer After Platinum-based First Line Chemotherapy (CheckMate 331: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 331)

Last checked: Nov 19, 2026Latest source record: Jul 27, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 569 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

569

Actual

Start

Sep 14, 2015

Primary completion

Aug 17, 2018

Study completion Aug 30, 2022

Sponsor

Lead sponsor
Bristol-Myers SquibbBristol Myers Squibb (BMY)
Sponsor type
Industry
Collaborators
Ono Pharmaceutical Co., Ltd.
First posted
Jun 25, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the overall survival of nivolumab versus chemotherapy in subjects with relapsed SCLC.

Conditions

  • Lung Cancer

Interventions

  • NivolumabDrug

  • TopotecanDrug

  • AmrubicinDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Survival (OS)Time frame: OS was followed continuously while participants were on the study drug and every 3 months, minimum follow up for overall survival was 15.8 months

Locations

151 sites in 25 countries. Site status is shown where the registry gives one.

  • Local Institution - 0065

    Little Rock, Arkansas

  • Local Institution - 0024

    New Haven, Connecticut

  • Local Institution - 0018

    Atlanta, Georgia

  • Local Institution - 0056

    St Louis, Missouri

  • Local Institution - 0088

    Lincoln, Nebraska

  • Local Institution - 0173

    Johnson City, New York

  • Local Institution - 0001

    Durham, North Carolina

  • Local Institution - 0090

    Cleveland, Ohio

  • Local Institution - 0002

    Bethlehem, Pennsylvania

  • Local Institution - 0057

    Lancaster, Pennsylvania

  • Local Institution - 0053

    Philadelphia, Pennsylvania

  • Local Institution - 0089

    Nashville, Tennessee

  • Local Institution - 0009

    Nashville, Tennessee

  • Local Institution - 0070

    Kennewick, Washington

  • Local Institution - 0027

    Murdoch, Australia

  • Local Institution - 0102

    Waratah, New South Wales, Australia

  • Local Institution - 0030

    Brisbane, Queensland, Australia

  • Local Institution - 0031

    Elizabeth Vale, South Australia, Australia

  • Local Institution - 0103

    Kurralta Park, South Australia, Australia

  • Local Institution - 0028

    Perth, Western Australia, Australia

  • Local Institution - 0085

    Graz, Austria

  • Local Institution - 0086

    Vienna, Austria

  • Local Institution - 0084

    Wels, Austria

  • Local Institution - 0013

    Brussels, Belgium

  • Local Institution - 0012

    Edegem, Belgium

  • Local Institution - 0011

    Leuven, Belgium

  • Local Institution - 0010

    Yvoir, Belgium

  • Local Institution - 0099

    São Paulo, Brazil

  • Local Institution - 0095

    Ijuí, Rio Grande do Sul, Brazil

  • Local Institution - 0094

    Porto Alegre, Rio Grande do Sul, Brazil

  • Local Institution - 0093

    Barretos, São Paulo, Brazil

  • Local Institution - 0025

    Recoleta, Santiago de Chile, Chile

  • Local Institution - 0201

    Beijing, China

  • Local Institution - 0198

    Guangzhou, China

  • Local Institution - 0182

    Hangzhou, China

  • Local Institution - 0192

    Shanghai, China

  • Local Institution - 0200

    Beijing, Beijing Municipality, China

  • Local Institution - 0199

    Beijing, Beijing Municipality, China

  • Local Institution - 0188

    Beijing, Beijing Municipality, China

  • Local Institution - 0190

    Beijing, Beijing Municipality, China

Showing 40 of 151 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.